These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20936634)

  • 1. A secreted variant of cartilage oligomeric matrix protein carrying a chondrodysplasia-causing mutation (p.H587R) disrupts collagen fibrillogenesis.
    Hansen U; Platz N; Becker A; Bruckner P; Paulsson M; Zaucke F
    Arthritis Rheum; 2011 Jan; 63(1):159-67. PubMed ID: 20936634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of mutant cartilage oligomeric matrix protein in human chondrocytes induces the pseudoachondroplasia phenotype.
    Merritt TM; Alcorn JL; Haynes R; Hecht JT
    J Orthop Res; 2006 Apr; 24(4):700-7. PubMed ID: 16514635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of PSACH-associated mutant COMP in tendon fibroblasts leads to increased apoptotic cell death irrespective of the secretory characteristics of mutant COMP.
    Weirich C; Keene DR; Kirsch K; Heil M; Neumann E; Dinser R
    Matrix Biol; 2007 May; 26(4):314-23. PubMed ID: 17307347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-type specific trafficking of expressed mutant COMP in a cell culture model for PSACH.
    Chen TL; Stevens JW; Cole WG; Hecht JT; Vertel BM
    Matrix Biol; 2004 Nov; 23(7):433-44. PubMed ID: 15579310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of extracellular matrix structure may cause pseudoachondroplasia phenotypes in the absence of impaired cartilage oligomeric matrix protein secretion.
    Schmitz M; Becker A; Schmitz A; Weirich C; Paulsson M; Zaucke F; Dinser R
    J Biol Chem; 2006 Oct; 281(43):32587-95. PubMed ID: 16928687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMP mutations, chondrocyte function and cartilage matrix.
    Hecht JT; Hayes E; Haynes R; Cole WG
    Matrix Biol; 2005 Jan; 23(8):525-33. PubMed ID: 15694129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondrocyte cell death and intracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plate.
    Hecht JT; Makitie O; Hayes E; Haynes R; Susic M; Montufar-Solis D; Duke PJ; Cole WG
    J Orthop Res; 2004 Jul; 22(4):759-67. PubMed ID: 15183431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis.
    Hashimoto Y; Tomiyama T; Yamano Y; Mori H
    Am J Pathol; 2003 Jul; 163(1):101-10. PubMed ID: 12819015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrilin-3 mutations that cause chondrodysplasias interfere with protein trafficking while a mutation associated with hand osteoarthritis does not.
    Otten C; Wagener R; Paulsson M; Zaucke F
    J Med Genet; 2005 Oct; 42(10):774-9. PubMed ID: 16199550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mice expressing D469Delta mutated cartilage oligomeric matrix protein (COMP) show growth plate abnormalities and sternal malformations.
    Schmitz M; Niehoff A; Miosge N; Smyth N; Paulsson M; Zaucke F
    Matrix Biol; 2008 Mar; 27(2):67-85. PubMed ID: 17889519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMP mutations: domain-dependent relationship between abnormal chondrocyte trafficking and clinical PSACH and MED phenotypes.
    Chen TL; Posey KL; Hecht JT; Vertel BM
    J Cell Biochem; 2008 Feb; 103(3):778-87. PubMed ID: 17570134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MED and PSACH COMP mutations affect chondrogenesis in chicken limb bud micromass cultures.
    Roman-Blas J; Dion AS; Seghatoleslami MR; Giunta K; Oca P; Jimenez SA; Williams CJ
    J Cell Physiol; 2010 Sep; 224(3):817-26. PubMed ID: 20578249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues.
    Hecht JT; Deere M; Putnam E; Cole W; Vertel B; Chen H; Lawler J
    Matrix Biol; 1998 Aug; 17(4):269-78. PubMed ID: 9749943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fate of cartilage oligomeric matrix protein is determined by the cell type in the case of a novel mutation in pseudoachondroplasia.
    Maddox BK; Keene DR; Sakai LY; Charbonneau NL; Morris NP; Ridgway CC; Boswell BA; Sussman MD; Horton WA; Bächinger HP; Hecht JT
    J Biol Chem; 1997 Dec; 272(49):30993-7. PubMed ID: 9388247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of TSP-5/COMP in pseudoachondroplasia.
    Posey KL; Hayes E; Haynes R; Hecht JT
    Int J Biochem Cell Biol; 2004 Jun; 36(6):1005-12. PubMed ID: 15094116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations of the cartilage oligomeric matrix protein (COMP) gene in two Japanese patients with pseudoachondroplasia.
    Nakayama H; Endo Y; Aota S; Sato M; Fujita T; Kikuchi S
    Oncol Rep; 2003; 10(4):871-3. PubMed ID: 12792737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudoachondroplasia and multiple epiphyseal dysplasia: New etiologic developments.
    Unger S; Hecht JT
    Am J Med Genet; 2001; 106(4):244-50. PubMed ID: 11891674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel and recurrent mutations in the calcium binding type III repeats of cartilage oligomeric matrix protein in patients with pseudoachondroplasia.
    Cao LH; Wang LB; Wang SS; Ma HW; Ji CY; Luo Y
    Genet Mol Res; 2011 May; 10(2):955-63. PubMed ID: 21644213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways.
    Dinser R; Zaucke F; Kreppel F; Hultenby K; Kochanek S; Paulsson M; Maurer P
    J Clin Invest; 2002 Aug; 110(4):505-13. PubMed ID: 12189245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined role of type IX collagen and cartilage oligomeric matrix protein in cartilage matrix assembly: cartilage oligomeric matrix protein counteracts type IX collagen-induced limitation of cartilage collagen fibril growth in mouse chondrocyte cultures.
    Blumbach K; Bastiaansen-Jenniskens YM; DeGroot J; Paulsson M; van Osch GJ; Zaucke F
    Arthritis Rheum; 2009 Dec; 60(12):3676-85. PubMed ID: 19950300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.